Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

26 Jul 2010 07:00

RNS Number : 8697P
Creston PLC
26 July 2010
 



 

 

 

Press Release 26 July 2010

 

Creston plc

Interim Management Statement 

 

Creston plc ("Creston" or the "Group") (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2010 to 25 July 2010.

 

Trading

 

As announced in Creston's preliminary statement on 28 June 2010 the Group has started the new financial year positively. The continuing Group post the disposal of DLKW Group on 14 July 2010 has delivered like-for-like revenue growth of 11 per cent for the 3 month period to 30 June 2010. This compares favourably to the 6 per cent like-for-like revenue decline reported for the comparable quarter of 2009 and the 4 per cent revenue decline reported for the financial year ending 31 March 2010.

 

The positive start to the new financial year has been driven by a number of new business wins including Astellas, Guinness, GSK, Shire Pharmaceuticals, Smith & Nephew, Sony Professional Services and ViiV.

 

Balance Sheet

 

Following the disposal of DLKW the Group had a positive cash balance of over £1 million on 14 July 2010 and access to an unutilised bank facility of £25 million.

 

Outlook

As a result of the first quarter growth in like-for-like revenue, demonstrating the quality and resilience of the continuing Group, and the momentum in new business wins, trading continues in line with management's and market expectations.

 

For further information, please contact:

 

Creston plc

020 7930 9757

Don Elgie, Chief Executive

 

Barrie Brien, COO/CFO

 

www.creston.com

 

 

 

M:Communications

 

Elly Williamson

020 7920 2339

 

 

 

 

About Creston plc

 

§ Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across-the-Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

 

§ Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients including: Amazon, AstraZeneca, Aviva, Bayer, BMW, BT, Burger King, Canon, COI Communications, Danone, Diageo, First Direct, GlaxoSmithKline, HTCJaguar, Kimberly-Clark, Land Rover, Lexus, Lloyds Black Horse, Nissan, O2, Pfizer, RocheDiagnostics, Royal Mail, Sainsbury's, Tesco, Thorpe Park, Toshiba, Toyota, T-Mobile, Tropicana, Unilever, Vodafone and Walkers.

 

§ Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASXDALLEEFF
Date   Source Headline
27th Jun 20113:11 pmRNSHolding(s) in Company
23rd Jun 20113:59 pmRNSHolding(s) in Company
23rd Jun 201112:40 pmRNSHolding(s) in Company
21st Jun 20113:21 pmRNSHolding(s) in Company
21st Jun 20117:00 amRNSFinal Results
20th Jun 20115:46 pmRNSHolding(s) in Company
10th Jun 20117:00 amRNSDirectorate Change
10th May 20119:59 amRNSAnnual Information Update
10th May 20117:00 amRNSInvestor & Analyst Presentation
20th Apr 20117:00 amRNSTrading Statement
13th Apr 201112:14 pmRNSHolding(s) in Company
7th Apr 20114:02 pmRNSHolding(s) in Company
17th Feb 20112:28 pmRNSHolding(s) in Company
16th Feb 20112:21 pmRNSHolding(s) in Company
16th Feb 201112:39 pmRNSHolding(s) in Company
3rd Feb 20117:00 amRNSInterim Management Statement
5th Jan 20113:10 pmRNSNotice of Interim Management Statement
22nd Dec 20109:56 amRNSCompletion of Acquisition
15th Dec 201012:40 pmRNSResult of Meeting
30th Nov 20107:00 amRNSInterim Results
30th Nov 20107:00 amRNSAcquisition
8th Nov 20102:18 pmRNSHolding(s) in Company
19th Oct 20101:09 pmRNSHolding(s) in Company
19th Oct 20101:07 pmRNSHolding(s) in Company
11th Oct 201011:12 amRNSNotice of Interim Results
28th Sep 20108:00 amRNSCreation of E-Healthcare Start-Up
2nd Sep 201010:55 amRNSAGM Statement
26th Jul 20107:00 amRNSInterim Management Statement
14th Jul 20104:12 pmRNSDirector/PDMR Shareholding
14th Jul 201011:54 amRNSDisposal
13th Jul 20109:51 amRNSResult of General Meeting
28th Jun 20104:30 pmRNSPosting of Circular
28th Jun 201010:35 amRNSHolding(s) in Company
28th Jun 20107:01 amRNSDisposal
28th Jun 20107:00 amRNSFinal Results
26th May 20104:52 pmRNSHolding(s) in Company
26th May 20108:40 amRNSNotice of Results
21st May 201012:56 pmRNSHolding(s) in Company
13th May 20105:46 pmRNSHolding(s) in Company
26th Apr 20102:13 pmRNSHolding(s) in Company
22nd Apr 20103:05 pmRNSHolding(s) in Company
20th Apr 20107:00 amRNSPre-Close Trading Statement
6th Apr 20104:29 pmRNSDirector/PDMR Shareholding
6th Apr 20104:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:41 pmRNSDirector/PDMR Shareholding
17th Feb 20105:51 pmRNSHolding(s) in Company
3rd Feb 20107:00 amRNSInterim Management Statement
10th Dec 20097:33 amRNSDirector/PDMR Shareholding
2nd Dec 20097:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.